Form 4: InfuSystem Holdings Director Acquires Stock Options

Kenneth D. Eichenbaum, a director of InfuSystem Holdings, Inc., was granted stock options to purchase 39,588 shares of common stock.

Summary

• On May 16, 2025, Kenneth D. Eichenbaum, a director of InfuSystem Holdings, Inc., acquired stock options.
• The options grant him the right to purchase 39,588 shares of InfuSystem Holdings, Inc. common stock at an exercise price of $6.
• These options vest on May 16, 2026, and expire on May 16, 2035.
• Eichenbaum also disposed of 4,000 shares of common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Positives

• The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.

Negatives

• The disposal of 4,000 shares of common stock by the director could be seen as a negative sign.

Risks

• The value of the stock options is dependent on the future performance of InfuSystem Holdings, Inc.'s stock price.
• There is no guarantee that the stock price will exceed the exercise price of $6 before the options expire.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders and their potential alignment with shareholder interests.

Comparison to Industry Standards

• Stock option grants are a common form of executive compensation in publicly traded companies, particularly in the healthcare and technology sectors.
• The size of the grant and the vesting schedule are typical for director-level compensation.
• Companies like Medtronic and Stryker also use stock options as part of their compensation packages for directors and executives.

Stakeholder Impact

• Shareholders may interpret the director's stock option acquisition as a sign of confidence in the company's future prospects.
• The disposal of shares may be interpreted negatively.

Key Dates

Keywords

stock options, director, InfuSystem Holdings, beneficial ownership, Form 4, securities